Regulatory Telemedicine Updates 2020: COVID-19

To minimize virus exposure risk and protect patient safety, providers are urged to conduct visits via telemedicine programs whenever possible throughout the duration of the COVID-19 health crisis. Several regulatory changes introduced in recent weeks aim to ease the process of implementing and utilizing telehealth services, lessening restrictions to allow physicians to continue providing much-needed …

National Rosacea Awareness Month: At-Home Rosacea Management Tips

The month of April celebrates Rosacea Awareness Month, designated by the National Rosacea Society to spread public awareness and education on the wide-ranging impact of the prevalent skin disorder. Current data estimates the chronic facial condition affects over 16 million Americans, causing discomfort and reducing quality of life. Thus, many patients with rosacea rely on …

Managing Eczema Patients During COVID-19

The novel coronavirus (COVID-19) outbreak carries significant implications for populations across the globe, healthcare systems, as well as the practice of medicine itself. Its effects can be detected across specialties and within the domain of aesthetic medicine, with an increasing number of providers switching to telemedicine and postponing procedures to reduce the risk of COVID-19 …

Biologic Therapy During COVID-19 

Shifting the model of healthcare around the world, the novel coronavirus (COVID-19) outbreak has significantly impacted the practice of medicine across all specialties, including dermatology and aesthetic medicine. The latest available knowledge suggests that certain demographics may face an increased risk of COVID-19 infection and serious illness, including elderly individuals, those with underlying medical conditions, …